Home
About
FAQ
History (1)
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy.
Clark PE. The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Kidney Int. 2009 Nov; 76(9):939-45.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antineoplastic Agents
Aryl Hydrocarbon Receptor Nuclear Translocator
Carcinoma, Renal Cell
Drug Design
Gene Expression Regulation, Neoplastic
Humans
Hypoxia-Inducible Factor 1, alpha Subunit
Kidney Neoplasms
Protein Kinase Inhibitors
Protein Kinases
Receptors, Vascular Endothelial Growth Factor
Signal Transduction
Treatment Outcome
Vascular Endothelial Growth Factor A
Von Hippel-Lindau Tumor Suppressor Protein
authors with profiles
Peter E. Clark MD